Find-Health-Articles.com - making medical research available to everyone
Research article summary (published 29 Sep 2003):
Free Full Text!
See links below

Human placental growth hormone, insulin-like growth factor I and -II, and insulin requirements during pregnancy in type 1 diabetes.

Full Abstract

Human placental GH (hPGH) replaces pituitary GH during pregnancy. hPGH is correlated to serum IGF-I in normal pregnancies and in pregnancies complicated by fetoplacental disorders. In gestational diabetes and type 2 diabetes no correlation between hPGH and IGF-I has been found. The relationship between hPGH and IGF-I in type 1 diabetes mellitus has not been investigated thoroughly. Furthermore, hPGH may be involved in the development of insulin resistance during pregnancy. In this prospective, longitudinal study, 51 type 1 diabetic subjects were followed with repeated blood sampling during pregnancy (median, 14 blood samples/subject; range, 8-26). Maternal concentrations of serum hPGH, IGF-I, and IGF-II were measured and compared with insulin requirements and birth characteristics. hPGH was detected from as early as 6 wk gestation. In all subjects, a rise in serum hPGH was observed during pregnancy, and the rise between wk 16 and 25 was correlated to the rise between wk 26 and 35 (P < 0.001). From wk 26 onward, the increase in hPGH values was significantly correlated to the birth weight, expressed as a z-score (r(s) = 0.54; P < 0.001), as were the absolute hPGH values. Also, a positive influence of hPGH on placental weight was found. Serum IGF-I values decreased significantly from the first to the second trimester (P

 

Author information

Author/s: Fuglsang, Jens (J); Lauszus, Finn (F); Flyvbjerg, Allan (A); Ovesen, Per (P);

Affiliation: Gynecological/Obstetrical Research Department Y, Aarhus University Hospital, Skejby Sygehus, DK-8200 Aarhus N, Denmark. jens_fuglsang(-atsign-)hotmail.com

Journal and publication information

Publication Type: Corrected and Republished Article; Journal Article; Research Support, Non-U.S. Gov't

Journal: The Journal of clinical endocrinology and metabolism (J Clin Endocrinol Metab), published in United States. (Language: eng)

Reference: 2003-Oct; vol 88 (issue 10) : pp 4355-61

Dates: Created 2003/10/14; Completed 2003/11/12; Revised 2006/11/15;

PMID: 14557493, status: MEDLINE (last retrieval date: 2/18/2009, IMS Date: )

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

Comments and Corrections

RepublishedFrom: J Clin Endocrinol Metab. 2003 Sep;88(9):4355-61. (PMID: 12970310)

External Links for this article
(including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.

MeSH headings (categories)

This article was linked to the MESH Headings shown below.

Associated Chemicals: Hemoglobin A, Glycosylated (0) ; Hypoglycemic Agents (0) ; Placental Hormones (0) ; HGH-V protein, human (109675-94-7) ; Insulin (11061-68-0) ; Insulin-Like Growth Factor I (67763-96-6) ; Insulin-Like Growth Factor II (67763-97-7) ; Growth Hormone (9002-72-6)

Related articles

These are the highest related articles currently in the database:

See 100+ related articles.

Related Article Map

12/30/1985
11/12/2007
Higher Relevance Score (26)
Lower Relevance Score (18)

Legend: - FREE Full text Article. - Abstract only. - Title only. More help.

See a large map of 100+ related articles.

© Advanogy LLC 2003-2009 - All rights reserved. Terms of Use | Contact Us | Index